The kidney and von Hippel-Lindau disease: impact of molecular genetic analysis of the VHL gene for clinical management.
Neumann
H P
HP
Department of Nephrology, Albert Ludwigs University, Freiburg, Germany. neumann@mm41.ukl.uni-freiburg.de
Bender
B U
BU
Schultze-Seemann
W
W
Krause
T
T
Altehoefer
C
C
Scheremet
R
R
Orszagh
M
M
Schwarzkopf
G
G
Januszewicz
A
A
Janetschek
G
G
Riegler
P
P
D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D005260:Female; D016147:Genes, Tumor Suppressor; D006801:Humans; D052177:Kidney Diseases, Cystic / Q000175:diagnosis / Q000209:etiology*; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D016030:Kidney Transplantation; D008025:Ligases; D008297:Male; D009154:Mutation; D011506:Proteins / Q000235:genetics*; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D006623:von Hippel-Lindau Disease / Q000150:complications / Q000175:diagnosis / Q000235:genetics
D011506:Proteins; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D008025:Ligases; C497446:VHL protein, human